GC's Struggles in Q2, Reversal Expected in H2?
There is a prediction in the securities industry that GC, which showed poor performance in Q2 this year,…
ALYGLO
4 개의 기사가 있습니다.
Will GC Biopharma's Immune Globulin 'Alyglo' Succeed in the U.S. Market?
GC Biopharma Corp's new immune globulin drug 'Alyglo' is set to enter the U.S. market after 8 years…
GC Biopharma's ALYGLO Signs Contract with Major U.S. PBM
GC Biopharma announced on the 2nd that it has signed a contract with a major Pharmacy Benefit Manager…
GC녹십자, 면역글로불린 혈액제제 'ALYGLO' 美 FDA 품목허가 재신청
GC녹십자는 자사의 혈액제제 ALYGLO(정맥투여용 면역글로불린10%)’에 대한 품목허가 신청서(BLA, Biologics License Application)를 미국 식품의약국(FDA)에 제출했다고 17일 공시했다. ALYGLO는 일차…